Does Novartis' delay in probing data manipulation claims spell trouble?
admin 23rd August 2019 Uncategorised 0Why did Novartis wait about two months before launching an internal probe into the alleged data manipulation surrounding gene therapy Zolgensma, and what was the Swiss drugmaker doing during those two months? That’s what officials at the FDA want to
read more